The analytical, intra-and inter-individual components of biological variation were estimated for protein C, protein S and antithrombin over a period of 6 weeks in a cohort of 17 apparently healthy subjects. Expressed as percentage activity (protein C and antithrombin) and as percentage concentration in normal human plasma (protein S), the mean values for men and women show no significant differences (p > 0.05) for any of the analytes studied. Calculated analytical goals (CV, %) for precision required for optimal patient care are: protein C, 2.9; protein S, 2.9 and antithrombin 2.7. A single numerical index, called "index of fiduciality", was also calculated to demonstrate that the analytical performance of our method was satisfactory. The generally applicable differences (% activity or % concentration) required for two results to be significantly different (p ^ 0.05) were calculated as: protein C, 17; protein S, 16 and antithrombin, 16. The usefulness of critical differences as guidelines for the interpretation of changes in serial results was investigated using an "index of heterogeneity" of intra-individual variation.
Introduction
six specimens from each subject over a period of Data on the biological variation of analyte concentrations have many valuable uses in clinical chemistry (1) , including setting desirable performance standards for Materials and Methods imprecision (2) , determining the true significance of changes in serial results from a single patient (3) and Sub J ects assessing the usefulness of conventional populationSeventeen apparently healthy hospital staff members (nine females based reference ranees (4) and eight men usual lifestyles throughout. None of the women was pregnant or ation of analytes in serum or plasma (5-7), the true using oral contraceptives, biological variation of the three naturally occurring anticoagulant proteins, protein C, protein S and antithrom-Specimen collection and handling bin (8) (9) , has not been investigated in depth. A previ-p reparation of the subjects before blood co ii ec tion was carefully ous Study on the biological variation of antithrombin has controlled, and blood collection was performed in standardized been reported (3), but in that article the discussion was conditions to minimize sources of preanalytical variation. After an ,. . ,
, .
-J--J1 ·· j · · ι i-rovernight fast, a blood specimen was taken with minimal venous limited to the mtra-mdividual variation and critical dif-Occlusion5 between 8 ^ 10 a . m . to avoid the influence of circaference.
dian variation on the plasma concentrations of the studied quantities. Six consecutive blood samples were taken weekly from each Since the values of these quantities are widely used in subject. All samples were drawn by the same phlebotomist from clinical decision making, we believe that their biological subjects in a supine position. The first 4 ml were discarded, and . . ι υ ι · j venous blood was then sampled into evacuated tubes containing variation should be examined.
129 mmol/1 ^souum citrate (Venoject VT-050SCBS, Terumo-,, r Al ,, j ι · ι· ι · ι · · · Europe, Leuven, Belgium). Plasma was obtained by centrifugation We therefore assessed their biological variation m a (2000gj ^ 4 o c for 10 min) ^ stored at _ 80 o c ^ ^ĉ ohort of 17 apparently healthy subjects, collecting At the end of 6 weeks, all frozen samples were transferred into a water bath at 37 °C for 15 minutes and then handled at room temperature.
Analytical techniques
The analytical protocol was designed to minimize analytical variance both within and between batches of analyses. Each set of specimens from an individual was assayed in duplicate, in no specific sequence, within the same analytical batch. Single lots of reagents, standards and quality-control materials were used throughout, and analyses were performed by a single operator. Comparability between runs was ensured by rigorous quality control. The activities of protein C and antithrombin were measured on a Hitachi 911 analyzer using a synthetic chromogenic substrate (antithrombin and Stachrom protein C, Boehringer Mannheim, Mannheim, Germany), while quantitative determination of protein S concentration was performed using a microlatex particle-mediated immunoassay (Liatest protein S, Boehringer Mannheim, Mannheim, Germany).
Statistical analysis of data
The detailed approach advocated by Fräser & Harris (1) was followed. After exclusion of outliers, nested analysis of variance (AN-OVA) was applied. The total variance was divided into the components attributable to analytical, intra-and inter-individual variation. Since, in assay procedures, quality control materials may not behave in the same way as specimens from patients (10), we calculated analytical variance from the results of duplicate analyses of each specimen. We used only the first of each duplicate result to calculate the average intra-individual variance and the inter-individual variance. Student's unpaired t-test was used to assess whether the means for men and women were different.
Results and Discussion

Analytical results
The mean values for men and women showed no significant difference (p < 0.05) for each of the analytes studied ( fig. 1 ). The data generated were therefore treated as a single set of data. -estimate the number of specimens required to produce a more precise estimate of the homeostatic set point of an individual.
Analytical goals
Stipulated standards of performance are necessary for the objective analysis of the data generated during the analytical investigation. It is widely accepted that analytical goals, the standards of analytical performance required to provide optimal patient care, are best derived from data on biological variation (11) . Goals for imprecision were derived as 1/2CVI (2). The goals for imprecision for all quantities were met in this study, as shown in 
Critical difference
The results of biochemical tests are often used in monitoring patients. It is therefore important to know the magnitude of the changes in serial results from an individual that amount to statistically significant differences. Such changes may be due not only to improvement or deterioration of the patient but also to analytical imprecision and intra-individual biological variation. Therefore, for a change to be significant, it must exceed the critical difference, which can be defined as the total variation required in serial results from an individual before significance can be claimed. Use of the average CVI to calculate critical differences is truly valid only if all subjects have the same CVI. This was investigated using an "index of heterogeneity" of intra-individual variation. This index is defined as the ratio of the observed CV of a set of individual variances (CVA 2 + CVI , where n is the average number of observations per subject (13) . If there were no heterogeneity of intra-individual variances, this ratio would be 1.00. When the index differs from unity by more than 2 SD, defined by 2/(2n) 1/2 , then significant heterogeneity exists. The calculated indices of heterogeneity for the analytes investigated are described in table 2. Since no index exceeds 1.00 by more than 2 SD, we believe that the critical differences detailed here are useful in clinical practice as guidelines in the interpretation of changes in serial results.
Our data on the critical difference and the CVI of antithrombin monitored over a six weeks period appear to be of the same order as those observed over six months by Costongs et al. (i.e., critical difference, 19.6%; CVI, 6.6%) (3). In Costongs' work the intraindividual variations and the critical differences of 9 coagulation quantities were investigated during short-term (within-one-day) and long-term (six months) periods. The antithrombin long-term CVI was found to be much smaller than the short-term one (16.3%), highlighting the fact that variations over the day should therefore be interpreted carefully.
Usefulness of conventional population-based reference values
Reference intervals are of particular importance when a test is used for screening or in making an initial diagnosis, when no previous data are available on an individual. The dispersion of conventional reference intervals is due to a composite of analytical, intra-and inter-individual variation. Conventional population-based reference values are of use only when the intra-individual variability exceeds the inter-individual variability. The ratio of the intra-to inter-individual biological variation, known as the "index of individuality" provides information on the utility of conventional population-based reference intervals (14) . When this index is less than 0.6, reference values are of limited utility, but when it is more than 1.4, such values are of considerable use. Table  2 shows the indices of individuality for protein C, protein S and antithrombin. For all the quantities, the index is < 0.6. This high degree of individuality means that subjects could have values that are very unusual for them but still lie within the conventional reference interval. Thus, the analytes examined in this study, although commonly assayed in clinical chemistry laboratories, will be of little use in the diagnosis of early or latent disease, or as general population-screening tests.
Number of specimens required
Since many analytes show considerable intra-individual variation, analyses of multiple specimens will produce a more precise estimate of the homeostatic set point. The required number of specimen collections needed to estimate the mean to within a desired precision, may be calculated from a rearrangement of the usual formula for the standard error of the mean:
where n is the number of specimens required, Z the number of standard deviates required for a stated probability under the normal curve, and D is the desired percentage closeness to the homeostatic set point (1).
For protein C, protein S and antithrombin we found that five of a patient's specimens are required to achieve a 95% chance that the mean is within ± 5% of the true value.
Conclusions
Data on analytical, intra-and inter-individual variation support the following conclusion:
-analytical goals derived from data on biological variation for protein C, protein S and antithrombin indicate that the standard of analytical performance achieved at present may be adequate for ideal patient care;
-the intra-individual variation exhibited by protein C, protein S and antithrombin means that, even when analytical goals for precision are met, relatively large differences (i.e., 16-17%) between sequential results are re-quired before two values can be said to be significantly different;
-population-based reference ranges are of limited value for the interpretation of results of measurements of protein C, protein S and antithrombin, because of the high degree of individuality for these quantities in plasma. Thus assays for protein C, protein S and antithrombin in plasma are likely to be useful in monitoring individuals but not in detecting disease with the desired nosological sensitivity.
-five specimens should be collected for protein C, protein S and antithrombin to estimate the homeostatic set point of an individual.
